Dexamethasone May Nix Immunotherapy Benefit in Glioblastoma ...Middle East

Medscape - News
Investigators found that baseline dexamethasone use was associated with poor overall survival (OS) in glioblastoma patients receiving anti–PD-1 or anti–PD-L1 therapy. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Dexamethasone May Nix Immunotherapy Benefit in Glioblastoma )

Apple Storegoogle play

Also on site :

Most viewed in News